Consulting
Topics to explore
Navigate Denmark’s New Healthcare Decision Landscape
From 2027, 17 local Health Councils will shape healthcare priorities and resource allocation across Denmark. Discover how disease-area data can help your Market Access and Public Affairs teams prepare for the change.
Explore the new decision landscape
Services
Topics to explore
Understand your patient
Gain clear insights into your patient care with our two top data solutions: Patient Impact Planner and Indication Insights.
Read more
Cases
Examples of our work
Browse the articles in this section to see examples of our work for other pharmaceutical companies.

If you’re interested in a specific service area, use the links on the right to navigate our portfolio.
Show me the cases
Topics to explore
Medice’s ADHD app launch: a digital health success story
Learn how Medice launched a commercially successful digital health app for ADHD families in Scandinavia.
Read the case
Insights
Signum Webinar on EU HTA: The Changing Global-Local Dynamic
Join Signum and Novo Nordisk for a practical discussion on how the EU HTA Regulation is reshaping collaboration between global and local market access teams.
Register now
Pharma Insights
We provide you with solid insight on which to base your strategy and tactical decisions. Some in a written format, others in the form of webinars.

Discover your options to the right - and let us know if you need anything else.
Sign up for our newsletter
Topics to explore
About
Your Nordic Partner
Signum supports your commercial growth across the four Nordic markets, with local teams in Denmark, Sweden, and Norway, as well as partnerships in Finland.
Learn about our Nordic services
Who are we
Decades of experience, in-depth knowledge of the Nordic markets and innovative data science make it possible for us to cut through the complexity to find the solutions you need for sound decision making.
Learn more
Topics to explore
Book a dialogue

Search

Menu

About
>
Our team
>
Chelsea Ranger

Chelsea Ranger, employee at Signum, Market Lead, Norway

Chelsea Ranger

Market Lead, Norway

chr@signumlifescience.com

+47 464 14 689

Chelsea leads Signum’s presence in Norway, supporting pharmaceutical companies with sales data, Real-World Evidence, Market Access, and strategic consulting. She works closely with clients to identify the data and insights they need to make informed decisions and improve patient access. Her focus is on establishing Signum as a trusted partner within the Norwegian health and life science ecosystem.

With more than 15 years of experience in health and life science commercialization, innovation, and investment, Chelsea has held senior roles at Possibia, The Life Science Cluster, SwedenBIO, and AMRA Medical. She is also an active mentor in the Novo Nordisk Foundation-funded NOME program, an investor and founder scout at Daya Ventures, and Founder and Chair of Wild Norway, a professional network promoting greater diversity and equity in Norway’s health and life science sector.